As of November 6, 2026, Aethlon Medical Inc. is a publicly traded company (Nasdaq: AEMD); its largest reported holder is Jane Street, with 5% on Schedule 13G of October 13, 2026. The largest insider holding is James B. Frakes, the chief executive and chief financial officer, with 42,063 shares (5.9% of shares outstanding), per Form 4 of October 13, 2026 (Schedule 13G, October 13, 2026).
Is this your company?
About to sign with, pay or invest in Aethlon Medical Inc.? See the free Snapshot first.
Free to see. No signup.
Is Aethlon Medical Inc. a real, registered company?
- Aethlon Medical Inc files with the SEC under CIK 882291 (its SEC filings).
- Its shares are listed under the ticker AEMD on Nasdaq (SEC company record).
- Incorporated in Nevada; business address in San Diego, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under AETHLON MEDICAL INC in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Jane Street (filed 2026-10-13).
Who are Aethlon Medical Inc.'s owners and officers?
Aethlon Medical Inc.: incorporated in Nevada; business address in San Diego, California; industry Surgical & Medical Instruments & Apparatus (Schedule 13G, 2026-10-13).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2025-12-23)
- : Director (Form D, 2025-12-23)
- : Director (Form D, 2025-12-23)
- : Director (Form D, 2025-12-23)
- : Director (Form D, 2025-12-23)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-10-13 | Jane Street Group, LLC | 5% |
| Schedule 13G/A, 2026-08-13 | Mitchell P. Kopin | 2.3% |
| Schedule 13G/A, 2026-05-15 | Armistice Capital, LLC | 4.99% |
| Schedule 13G, 2026-02-17 | Armistice Capital, LLC | 9.99% |
| Schedule 13G/A, 2026-02-17 | Alumni Capital LP | 4.05% |
| Schedule 13G/A, 2025-11-14 | Ikarian Capital, LLC | 2% |
| Schedule 13G/A, 2025-11-14 | Armistice Capital, LLC | 4.99% |
| Schedule 13G, 2025-09-22 | Alumni Capital LP | 9.58% |
| Schedule 13G, 2025-09-10 | Mitchell P. Kopin | 7.7% |
| Schedule 13G/A, 2025-08-14 | Armistice Capital, LLC | 7.16% |
Questions about who owns Aethlon Medical Inc.
Who owns Aethlon Medical Inc.?
On this page, one holder's latest ownership filing reports 5% or more of Aethlon Medical Inc.: Jane Street Group, LLC (5%, Schedule 13G, filed 2026-10-13).
When did Jane Street Group, LLC buy into Aethlon Medical Inc.?
The filings give report dates, not purchase dates. The earliest filing from Jane Street Group, LLC on this page is the Schedule 13G, filed 2026-10-13, reporting 5%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 10 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Aethlon Medical Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Aethlon Medical Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Aethlon Medical Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
22 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Aethlon Medical Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and chief financial officer: 42,063 shares (5.9% of shares outstanding) (Form 4, 2026-10-13).
- , the chief medical officer: 42,057 shares (5.9% of shares outstanding) (Form 4, 2026-10-15).
- , a director: 4,846 shares (0.68% of shares outstanding) (Form 4/A, 2026-10-15).
- , a director: 4,313 shares (0.61% of shares outstanding) (Form 4, 2026-10-15).
- , M.D., a director: 3,787 shares (0.53% of shares outstanding) (Form 4, 2026-10-15).
Shares outstanding: 711,136 as of 2026-08-10, from the company's latest SEC cover page.
How much has Aethlon Medical Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-12-23 | $2.15M | $2.15M |
Latest IPO step: Aethlon Medical Inc. amended its IPO registration (S-1/A, 2026-07-01).
IPO filings: S-1/A, 2026-07-01, S-1/A, 2026-07-01, S-1, 2026-06-22, S-1, 2026-01-07, 424B4, 2025-09-05.
Keep reading
More on Aethlon Medical Inc. and the records around it.
Aethlon Medical Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
- Form D filing Dec 2025
Companies that share a holder
- Alumni Capital LP also filed stake reports on 12 other companies: reAlpha Tech Corp. (Nov 2026), Sports Entertainment Gaming Global Corp (Nov 2026), NEXALIN TECHNOLOGY, INC. (Aug 2026)
- Ikarian Capital, LLC also filed stake reports on 22 other companies: Quoin Pharmaceuticals Ltd. (Oct 2026), Connect Biopharma Holdings Limited (Aug 2026), Galera Therapeutics, Inc. (Aug 2026)
- Mitchell P. Kopin also filed stake reports on 55 other companies: SCWorx Corp. (Sep 2026), NFT Limited (Aug 2026), Silexion Therapeutics Corp (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/aethlon-medical